DarioHealth Corp (NAS:DRIO)

$ 0.865 -0.025 (-2.81%) Market Cap: 27.09 Mil Enterprise Value: 35.57 Mil PE Ratio: 0 PB Ratio: 0.38 GF Score: 57/100

Q3 2024 DarioHealth Corp Earnings Call Transcript
5 days ago

$0.9702 (+0.52%)

Earnings
Q2 2024 DarioHealth Corp Earnings Call Transcript
Aug 08, 2024

$0.8349 (-9.94%)

Earnings
Q1 2024 DarioHealth Corp Earnings Call Transcript
May 15, 2024

$1.85 (+6.94%)

Earnings
Q4 2023 DarioHealth Corp Earnings Call Transcript
Mar 28, 2024

$1.53 (+0.66%)

Earnings
Q3 2023 DarioHealth Corp Earnings Call Transcript
Nov 02, 2023

$1.01

Earnings
DarioHealth Corp To Host Investor Day Transcript
Oct 17, 2023
Q2 2023 DarioHealth Corp Earnings Call Transcript
Aug 10, 2023

$3.15 (-8.43%)

Earnings
DarioHealth Corp at Stifel Cross Sector Insight Conference Transcript
Jun 06, 2023
Q1 2023 DarioHealth Corp Earnings Call Transcript
May 11, 2023

$3.86 (+4.32%)

Earnings
Q4 2022 DarioHealth Corp Earnings Call Transcript
Mar 09, 2023

$4.44 (-9.94%)

Earnings
Q3 2022 DarioHealth Corp Earnings Call Transcript
Nov 15, 2022

$4.91 (+25.26%)

Earnings
Q2 2022 DarioHealth Corp Earnings Call Transcript
Aug 15, 2022

$6.74 (-5.87%)

Earnings
Q1 2022 DarioHealth Corp Earnings Call Transcript
May 12, 2022

$5.18 (+13.35%)

Earnings
Q4 2021 DarioHealth Corp Earnings Call Transcript
Mar 22, 2022

$6.6 (+1.69%)

Earnings
DarioHealth Corp Investor Webinar Transcript
Jan 19, 2022
Q3 2021 DarioHealth Corp Earnings Call Transcript
Nov 16, 2021

$16.27 (-2.57%)

Earnings
DarioHealth Corp at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 09, 2021
DarioHealth Corp at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 30, 2021
Q2 2021 DarioHealth Corp Earnings Call Transcript
Aug 16, 2021

$10.47 (-12.31%)

Earnings
Q1 2021 DarioHealth Corp Earnings Call Transcript
May 18, 2021

$14.81 (+1.16%)

Earnings
Q4 2020 DarioHealth Corp Earnings Call Transcript
Mar 09, 2021

$21.02 (-0.61%)

Earnings
DarioHealth Corp at Cowen Healthcare Conference (Virtual) Transcript
Mar 01, 2021
DarioHealth Corp. - Special Call Transcript
Jan 27, 2021
Q3 2020 DarioHealth Corp Earnings Call Transcript
Nov 12, 2020

$11.61 (+6.32%)

Earnings
Q2 2020 DarioHealth Corp Earnings Call Transcript
Aug 12, 2020

$14.7 (+8.17%)

Earnings
DarioHealth Corp and RCA Financial Partners Discussion on B2B Business Development Strategy Call Transcript
Jul 07, 2020
DarioHealth Corp. - Special Call Transcript
Jun 23, 2020
Q1 2020 DarioHealth Corp Earnings Call Transcript
May 12, 2020

$7 (-11.95%)

Earnings
Q4 2019 DarioHealth Corp Earnings Call Transcript
Mar 17, 2020

$4.75 (+3.26%)

Earnings
Q3 2019 DarioHealth Corp Earnings Call Transcript
Oct 28, 2019

$5.24 (-6.43%)

Earnings
Q2 2019 DarioHealth Corp Earnings Call Transcript
Aug 13, 2019

$8.4 (-25.66%)

Earnings
Q1 2019 DarioHealth Corp Earnings Call Transcript
May 13, 2019

$16.6 (-3.88%)

Earnings
Q4 2018 DarioHealth Corp Earnings Call Transcript
Mar 25, 2019

Earnings

DarioHealth Corp. - Special Call Transcript

Jan 27, 2021 / 01:30PM GMT

Release Date Price: $21.92 (-6.68%)

Transcript

Operator

Greetings, and welcome to the DarioHealth Conference call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Glenn Garmont, Investor Relations for DarioHealth. Thank you. You may begin.

Glenn Garmont

LifeSci Advisors, LLC - MD

Thank you, Melissa. Good morning, everyone, and thank you for joining us today for the DarioHealth conference call to discuss the financing and acquisition of Upright. Leading the call today will be Erez Raphael, President and Chief Executive Officer of DarioHealth; and he'll be joined by Rick Anderson, President and General Manager of North America at DarioHealth.

We issued a press release this morning, which can be found on the Investor Relations page of the company's website, www.dariohealth.com. An audio recording and webcast replay for today's conference call will also be available online as detailed in the press release. For the benefit of those who may be listening to

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.